CC
MRK icon

Centiva Capital’s Merck MRK Stock Holding History

Centiva Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Buy
5,405
+2,397
+80% +$281K 0.01% 762
2026
Q1 		$362K Sell
3,008
-11,753
-80% -$1.36M ﹤0.01% 979
2025
Q4 		$1.55M Sell
14,761
-130,624
-90% -$12.3M 0.01% 480
2025
Q3 		$12.2M Buy
145,385
+52,262
+56% +$4.3M 0.12% 135
2025
Q2 		$7.37M Buy
93,123
+75,021
+414% +$5.96M 0.12% 109
2025
Q1 		$1.62M Sell
18,102
-6,143
-25% -$574K 0.05% 251
2024
Q4 		$2.41M Buy
24,245
+22,579
+1,355% +$2.33M 0.05% 243
2024
Q3 		$189K Sell
1,666
-45,628
-96% -$5.42M ﹤0.01% 1843
2024
Q2 		$5.85M Buy
47,294
+36,622
+343% +$4.72M 0.1% 126
2024
Q1 		$1.41M Buy
10,672
+10,543
+8,173% +$1.3M 0.03% 494
2023
Q4 		$14.1K Sell
129
-10,622
-99% -$1.1M ﹤0.01% 1684
2023
Q3 		$1.11M Buy
+10,751
New +$1.16M 0.02% 582
2023
Q2 		– Sell
-130,876
Closed -$14.9M – 1853
2023
Q1 		$13.9M Buy
130,876
+118,838
+987% +$12.8M 0.34% 45
2022
Q4 		$1.34M Buy
12,038
+9,739
+424% +$995K 0.04% 472
2022
Q3 		$198K Buy
+2,299
New +$205K ﹤0.01% 1182
2022
Q2 		– Sell
-9,252
Closed -$820K – 1880
2022
Q1 		$759K Buy
+9,252
New +$729K 0.01% 812
2021
Q2 		– Sell
-23,422
Closed -$1.72M – 1528
2021
Q1 		$1.72M Sell
23,422
-5,588
-19% -$412K 0.07% 216
2020
Q4 		$2.26M Buy
29,010
+11,636
+67% +$890K 0.09% 136
2020
Q3 		$1.38M Sell
17,374
-10,358
-37% -$811K 0.09% 159
2020
Q2 		$2.05M Buy
27,732
+17,386
+168% +$1.31M 0.12% 98
2020
Q1 		$759K Sell
10,346
-3,830
-27% -$301K 0.03% 259
2019
Q4 		$1.23M Buy
14,176
+6,857
+94% +$563K 0.06% 261
2019
Q3 		$588K Buy
+7,319
New +$587K 0.04% 287

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centiva Capital's MRK Position: Q2 2026 in Review

Centiva Capital increased its Merck (MRK) stake by 80% in Q2 2026, buying an estimated $281K and bringing the position to 5,405 shares worth $695K. The position accounts for 0.01% of the portfolio, ranked #762.

Centiva Capital first reported a position in MRK in Q3 2019 and has held it in 23 quarters since. The position peaked at $13.9M in Q1 2023. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Centiva Capital held 5,405 shares of Merck worth $695K as of Q2 2026.
  • Centiva Capital bought 2,397 Merck shares in Q2 2026, an estimated $281K.
  • Merck made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #762 holding.
  • Centiva Capital first reported a position in Merck in Q3 2019 and has held it in 23 quarters since.
  • Centiva Capital's Merck position peaked at $13.9M in Q1 2023.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.